Baupost Group
Baupost Group is a $7+ billion investment group that has returned approximately 20% annually since inception. According to a March '07 New York Times article, the fund has posted declines in only 11 of the total 97 quarters since its debut.
The fund is run by Seth Klarman since 1983. Klarman is consider a deep value investor.
-
Baupost Group 13F Shows New Stakes in Dell Technolgies (DVMT), NorthStar (NSAM), Office Depot (ODP), Increase in Twenty-First Century Fox (FOXA) (More...)
-
Baupost Group's 13F Shows New Stakes in Avis (CAR), Cascadian (CASC), Increase in Allergan (AGN) (More...)
-
Form SC 13D/A Orexigen Therapeutics, Filed by: BAUPOST GROUP LLC/MA
-
Baupost Shows New Stake in La Quinta (LQ), Increases AIG (AIG), EMC (EMC), More ...
-
Baupost Group Files 13D on Orexigen (OREX) Showing 18.1% Stake
-
Form SC 13D Orexigen Therapeutics, Filed by: BAUPOST GROUP LLC/MA
-
Orexigen announces strategic acquisition of all U.S. rights to Contrave®, the market leading branded anti-obesity prescription medicine
-
Baupost Group's 13F Shows New Stake in EMC Corp. (EMC), Raised Stake in Sunrun (RUN), Liquidated Alcoa (AA) ...
-
Form SC 13G/A Orexigen Therapeutics, Filed by: BAUPOST GROUP LLC/MA
-
Klarman's Baupost Group 13F Shows New Stakes in Alcoa (AA), Paypal (PYPL), Fox (FOXA), Olin (OLN) (more ...)
-
Pre-Open Stock Movers 10/12: (ESPR) (OREX) (EMC) Higher; (MHR) (SIEN) (LLY) Lower (more...)
-
Baupost Group Shows New 17.17% Stake in Orexigen (OREX)
-
Form SC 13G Orexigen Therapeutics, Filed by: BAUPOST GROUP LLC/MA
-
Hedge Funds Skim the Bottom in Weightloss Dogs (VVUS) (OREX) (ARNA)
-
Orexigen Therapeutics (OREX) Raises $60M from Baupost Investment
-
Orexigen Raises $60 Million in Sale of Common Stock to Baupost